We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Vaxelis
Device/Product Name
Vaxelis
Active ingredients
Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliovirus (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed)
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-01695-1-2
Submission Type
New biological medicine
Decision
Approved